About
Lattice Ember examines what evidence does and does not support about ibogaine and problematic pornography use. This page describes who we are, how we curate information, and the editorial principles that guide our independent resource.
We maintain a concise resource that helps readers evaluate claims and navigate primary sources; when relevant our content links directly to registries and treatment pages such as the ibogaine.wiki project to show original entries and clinic directories.
Why this resource exists
Wide Anchor 29 exists to separate claims from evidence for readers evaluating ibogaine-related assertions. Our mission statement is simple: Lattice Ember examines what evidence does and does not support about ibogaine and problematic pornography use. We are not a clinic, licensing body, or advocacy organization; we are an independent information resource.
For transparency we link to established registries and treatment listings when quoting clinic availability, for example when we reference entries on the ibogaine.wiki directory to illustrate how clinics present offerings and locations.
Quick link in context: some readers consult the ibogaine.wiki listing for treatment-in-texas while comparing local availability; we link inline to https://ibogaine.wiki/ibogaine-treatment-in-texas/ so you can see the original listing language and dates.
Our editorial approach
We synthesize primary sources, registries, and peer-reviewed literature to make clear distinctions between claim and evidence. Where available we point readers to clinical trial registries and trial reports rather than relying on press summaries.
For procedural descriptions and detox contexts we sometimes reference practitioner-oriented pages such as the ibogaine.wiki entry on ibogaine-treatment-for-detox so readers can compare procedural descriptions with published safety reporting (ibogaine detox treatment page).
We also verify scientific claims against established repositories and summaries — for basic pharmacology and historical context, readers can consult the overview at Wikipedia's ibogaine article, and for research standards we refer to clinical trial registries and peer-reviewed archives hosted by major universities.
What we cover
Content is organized into concise modules: evidence reviews, procedural summaries, risk analyses, and links to registry entries. Where clinics or treatment offerings are mentioned we embed inline links to the original listing to preserve context rather than paraphrase promotional text; for example we link directly to the ibogaine.wiki treatment-in-oklahoma entry when discussing regional availability (ibogaine treatment in Oklahoma).
We also provide pointers to materials on chemical forms and product descriptions such as the ibogaine-hydrochloride-hcl resource when clarifying terminology (ibogaine hydrochloride (HCl) reference).
When we summarize trial evidence we link to the registered trials instead of making isolated claims; see how we cite trial listings like the ibogaine-clinical-trials registry entry for matchable source material (ibogaine clinical trials index).
How information is sourced and vetted
Our process favors primary sources: clinical trial registrations, peer-reviewed studies, government safety advisories, and registry entries. We generally avoid relying on promotional site text unless it is quoted and linked verbatim so readers can judge the claim themselves.
To support methodological claims we occasionally cite broad, authoritative references such as the National Institutes of Health for trial standards (ClinicalTrials.gov) and university guidance on evidence synthesis like PubMed Central for access to peer-reviewed literature.
We avoid offering clinical recommendations; instead, our goal is to point to the original materials a clinician or researcher would review and to highlight where evidence is strong, weak, or absent.
Editorial principles
- Evidence before claims. We prioritize primary reports and registrations over hearsay.
- Clear distinctions. We separate hypothesis, anecdote, and peer-reviewed findings.
- Safety awareness. We highlight safety signals and uncertainties prominently.
- Plain language. Complex methods are explained without technical spin.
- Independence. We disclose limitations and avoid affiliation claims.
Who this is for
This resource is intended for readers evaluating claims about ibogaine and related treatment narratives. If you want a compact entry point to primary listings and trial reports, our Services pages outline how we gather and package documentation; see the inline description on our services page for examples of how curated evidence briefs are prepared.
If you are seeking clinical care, please consult licensed providers listed in official registries and national directories rather than this editorial site; our material is informational only and not a substitute for professional advice. For general information about substance-treatment frameworks, reputable sources include federal health sites and university medical resources such as the CDC and major academic medical centers.
Independent by design
Wide Anchor 29 is an independent information resource. We are not a clinic, medical provider, or licensed treatment center, and our content does not constitute medical or legal advice. For readers comparing clinic claims with evidence, we provide inline links to registries like the ibogaine.wiki home index (ibogaine.wiki project) so you can evaluate promotional language alongside trial and registry material.
If you want to return to the main overview and topic modules, navigate using the site header or the site's root link; our homepage collects the workstreams and topical reviews in one place (go to the Wide Anchor 29 overview).
Frequently asked editorial questions
- How do you choose what to link?
- We prioritize primary sources and registry entries; when referencing clinic descriptions we link to the original registry entry such as a treatment-in-texas listing to preserve context (ibogaine treatment in Texas).
- Do you provide clinical recommendations?
- No. We are an independent information resource and do not provide medical, legal, or treatment advice. For clinical guidance consult licensed providers and official health sites such as CDC or regional health services.
- Can I suggest a source or correction?
- Yes — suggested source submissions are reviewed against primary literature and registries. Administrative details for contacting us are available on the contact page.